Pharmacology
News
Antidepressant shows early promise for mild COVID-19
The findings on fluvoxamine “need to be interpreted as hypothesis generating rather than as a demonstration of efficacy,” the study authors wrote...
News
FDA authorizes baricitinib combo for COVID-19
Conference Coverage
‘Uptake is only the first step’ for effective HIV PrEP protection
Follow-up in patients who received HIV PrEP prescriptions through a Detroit program was under 50%.
Article
Can a probiotic prevent COVID-19?
Dr. Anthony Sung describes a trial testing whether a probiotic can prevent COVID-19.
Conference Coverage
First SGLT1/2 inhibitor shows ‘spectacular’ phase 3 safety and efficacy in T2D
A pair of pivotal trials showed safety and efficacy for sotagliflozin for patients with type 2 diabetes, including novel benefits from an SGLT...
Conference Coverage
Osteoporosis drugs don’t worsen COVID-19 risk, may help
“What we observed is that there is no harm. Treatments should be continued.”
Conference Coverage
VTEs tied to immune checkpoint inhibitor cancer treatment
Retrospective analysis hints that cancer patients have an elevated risk for venous thromboembolism following treatment with an immune checkpoint...
News
Pembrolizumab approved for triple-negative breast cancer
This is the first breast cancer indication for pembrolizumab.
Conference Coverage
Intravenous iron reduces HF readmissions: AFFIRM-AHF
The results are likely to change heart failure guidelines, which currently give a lukewarm recommendation for intravenous iron in the US, experts...
Conference Coverage
Escalate HIV adherence strategies amid COVID-19